|
|
|
|
Panbela Therapeutics Inc (PBLA) |
|
|
|
|
|
Panbela Therapeutics Inc's Suppliers Performance
PBLA's Supply Chain
|
Select the Relationship:
|
|
Select the Category:
|
|
News about
Panbela Therapeutics Inc Contracts
|
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to developing groundbreaking therapeutics for patients with urgent unmet medical needs, recently announced the favorable outcome of the third independent safety review of their ongoing Phase 3 ASPIRE clinical trial. This trial aims to evaluate the efficacy and safety of ivospemin in combination with gemcitabine and nab-Paclitaxel as a first-line treatment for metastatic pancreatic ductal adenocarcinoma (mPDAC). The Data Safety Monitoring Board (DSMB) recommended the trial's continuation without modification, marking the third consecutive positive safety review. This article aims to highlight the significance of these findings an...
|
- An Unprecedented Pivotal Turn in Panbela?s Clinical Trials -In a recent development for clinical-stage pharmaceutical company, Panbela Therapeutics, Inc., the interim data analysis regarding its ASPIRE trial has been scheduled for release in Q1, 2025. The reason for this ground-breaking development is deeply intertwined with the trial's surprising lower-than-expected event rate, which researchers are suggesting could indicate an improvement in patient survival outcomes.Considered as a significant turn in the clinical trial's journey, this recent revelation shouldn't be taken lightly. Especially considering the critical nature of Panbela's mission ?? to develop disruptive therapeutics for the treatment of p...
|
Panbela Therapeutics Inc's Comment on Supply Chain
PBLA's vs. Suppliers, Data
(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
